Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Effect of Epoxide Hydratase on Benzo[a]pyrene Diol Epoxide Hydrolysis and Binding to DNA and Mixed-Function Oxidase Proteins

E. M. GOZUKARA, G. BELVEDERE, R. C. ROBINSON, J. DEUTSCH, M. J. COON, F. P. GUENGERICH and H. V. GELBOIN
Molecular Pharmacology January 1981, 19 (1) 153-161;
E. M. GOZUKARA
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205, Department of Biological Chemistry, The University of Michigan, Ann Arbor, Michigan 48109, and Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. BELVEDERE
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205, Department of Biological Chemistry, The University of Michigan, Ann Arbor, Michigan 48109, and Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. C. ROBINSON
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205, Department of Biological Chemistry, The University of Michigan, Ann Arbor, Michigan 48109, and Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. DEUTSCH
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205, Department of Biological Chemistry, The University of Michigan, Ann Arbor, Michigan 48109, and Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. J. COON
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205, Department of Biological Chemistry, The University of Michigan, Ann Arbor, Michigan 48109, and Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. P. GUENGERICH
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205, Department of Biological Chemistry, The University of Michigan, Ann Arbor, Michigan 48109, and Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. V. GELBOIN
Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20205, Department of Biological Chemistry, The University of Michigan, Ann Arbor, Michigan 48109, and Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

A reconstituted purified mixed-function oxidase (MFO) system converts 3H(-)t-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene [3H(-)t-7,8-dihydrodiol BP] to r-7,t-8-dihydroxy-t-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene (diol epoxide I) and r-7,t-8-dihydroxy-c-9,10-oxy-7,8,9,10-tetrahydrobenzo[a]pyrene (diol epoxide II). The addition of DNA to the incubation mixture results in covalent binding of metabolites to DNA. The binding of metabolites to DNA is a linear function of cytochrome P-450 LM4 content. The addition of epoxide hydratase reduces the binding of metabolites to DNA by 35%-43%. Human monocytes, lymphocytes, and Fisher rat liver cells (TRL-2) also catalyze the binding of 3H(-)t-7,8-dihydrodiol BP to added DNA. Cells that have been induced by benzanthracene (BA) exhibit greater levels of DNA binding. The addition of epoxide hydratase to the medium reduces the amount of reactive metabolites binding to DNA by 54% and 31% in control and induced monocytes, 45% and 26% in control and induced lymphocytes, and by 18%-28% in control and 13%-24% in BA-preinduced rat liver TRL-2 cells. Thus, with both purified reconstituted MFO systems or with whole cell systems of either human monocytes, lymphocytes, or rat cells, the addition of purified epoxide hydratase reduces the binding of 3H(-)t-7,8-diol metabolites to DNA. These results indicate that epoxide hydratase functions in the hydrolytic inactivation of the diol epoxides. When heat-inactivated epoxide hydratase was used, no alteration in DNA binding was detected. The MFO system autocatalyzes the binding of 3H(-)t-7,8-dihydrodiol BP to the two protein components of the MFO enzyme system. The metabolites are bound to cytochrome P-450 LM4 to the greatest extent both with respect to specific activity and total binding and to a lesser extent to cytochrome c (P-450) reductase. DNA can compete for reactive metabolite since the addition of DNA considerably reduces the binding of metabolites to the protein components. Added bovine serum albumin is also covalently bound to metabolites but does not reduce the binding to either DNA or the purified proteins of the enzyme system. Added epoxide hydratase is also covalently bound and reduces the binding to the other proteins. Diol epoxide I and II hydrolysis was measured by high-pressure liquid chromatography of the four tetrol products. The addition of DNA reduced the formation of tetrols I-2 (7/8,8,10), II-1 (7,9/8,10), and II-2 (7,9,19/8) and had no effect on the major I-1 (7,10/8,9) tetrol, indicating a stereoselective effect of DNA on diol epoxide hydrolysis. The addition of epoxide hydratase reduced the formation of three of the four tetrols by 11%-44% and increased tetrol II-1 formation, indicating a hydratase-induced alteration in the ratio of hydrolysis products. The latter results and the inhibition of DNA binding by hydratase indicate that the hydratase has a stereospecific interaction with diol epoxides, binding them covalently, altering their mode of hydrolysis, and apparently reducing their activity as carcinogenic intermediates that bind to DNA. Thus, epoxide hydratase may play am important role in diol epoxide detoxification.

ACKNOWLEDGMENTS We thank Drs. A. C. Peacock and K. Robie-Suh of the National Cancer Institute for carefully reading and reviewing this paper and D. M. McCourt and H. Miller for their helpful technical assistance.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 19, Issue 1
1 Jan 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Effect of Epoxide Hydratase on Benzo[a]pyrene Diol Epoxide Hydrolysis and Binding to DNA and Mixed-Function Oxidase Proteins
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Effect of Epoxide Hydratase on Benzo[a]pyrene Diol Epoxide Hydrolysis and Binding to DNA and Mixed-Function Oxidase Proteins

E. M. GOZUKARA, G. BELVEDERE, R. C. ROBINSON, J. DEUTSCH, M. J. COON, F. P. GUENGERICH and H. V. GELBOIN
Molecular Pharmacology January 1, 1981, 19 (1) 153-161;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Effect of Epoxide Hydratase on Benzo[a]pyrene Diol Epoxide Hydrolysis and Binding to DNA and Mixed-Function Oxidase Proteins

E. M. GOZUKARA, G. BELVEDERE, R. C. ROBINSON, J. DEUTSCH, M. J. COON, F. P. GUENGERICH and H. V. GELBOIN
Molecular Pharmacology January 1, 1981, 19 (1) 153-161;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antimicrobial and Antileukemic Transportan 10 Conjugates
  • Pharmacological characterization of zebrafish H1 receptor
  • Bhave and Forman
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics